Research Directory

Highlights from the 2020 ASCO virtual meeting

Read more

New cancer drugs have unique mechanisms of action

Read more

Late-stage oncology pipeline is robust

Read more

The US continues to lead in oncology approvals

Read more

Oncology Review: New drugs target niche tumours, expand patient benefit

Read more

ASCO 2019: Successes and setbacks mark the cancer meeting

Read more

Single-arm studies set the pace of oncology

Read more

The productivity of oncology development continues

Read more

The oncology drug success rate is improving

Read more

ASCO 2018: Oncology trials break new ground

Read more